πŸ‡ΊπŸ‡Έ FDA
Patent

US 11814657

Modified DNase and uses thereof

granted A61KA61K38/00A61K38/465

Quick answer

US patent 11814657 (Modified DNase and uses thereof) held by Protalix Ltd. expires Mon Nov 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Protalix Ltd.
Grant date
Tue Nov 14 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K38/00, A61K38/465, A61P, A61P11/00